Dollvet


Veterinary biotechnology company based in Şanlıurfa, Turkey, focused on research, development and GMP-compliant manufacture of veterinary vaccines, hyperimmune sera, diagnostic test kits and other animal health products. Operates a large sterile production campus with an in-house R&D center approved by the Ministry of Industry and Trade, holds multiple veterinary product licenses and participates in export and international trade events.

Industries

biopharma
biotechnology
chemical
life-science
manufacturing

Nr. of Employees

medium (51-250)

Dollvet


Products

Inactivated multivalent mastitis vaccine (oil-adjuvanted)

Inactivated bacterial vaccine developed for protection against common mastitis pathogens in cattle including Escherichia coli, Staphylococcus aureus and Mycoplasma bovis.

Multivalent hyperimmune neonatal serum

Hyperimmune antisera developed using local strains to provide passive protection to newborn calves, lambs and kids against multiple enteric and systemic pathogens.

Inactivated Pasteurella / Mannheimia bacterial vaccines

Injectable inactivated bacterial vaccines for prevention of pasteurellosis and mannheimiosis in ruminants.

Topical antiparasitic formulations (spot-on and sprays)

Topical spot-on solutions and spray formulations for control of fleas, ticks and other ectoparasites.

Diagnostic test kits (for veterinary pathogens)

Commercial diagnostic kits for serological detection used in product evaluation and field diagnostics.


Services

Manufacture and commercial supply of veterinary vaccines, hyperimmune sera, diagnostic kits and antiparasitic formulations.

In-house R&D center approved by the Ministry, conducting multi-year development of vaccines and antisera.

Expertise Areas

  • Veterinary vaccine development
  • Biological product GMP manufacturing
  • Hyperimmune serum development
  • Veterinary diagnostics and test kits
  • Show More (4)

Key Technologies

  • Lyophilization (freeze-drying)
  • Fermentation and bioreactor processing
  • HEPA-filtered cleanroom production
  • Oil-adjuvanted vaccine formulation
  • Show More (3)

News & Updates

Participation in Agritec Africa 2025 exhibition to present veterinary health solutions to international markets.

Facility visits and launch events for a new hyperimmune serum product attended by approximately 100 veterinarians.

Announcement of a multi-year R&D program and readiness of an inactivated multivalent mastitis vaccine candidate.

Article on the role and demonstrated effects of a non-specific immunostimulant for strengthening animal immune responses.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.